Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Kamna Balhara"'
Autor:
Jonathan M. Kurie, Ignacio I. Wistuba, Walter N. Hittelman, Roger E. Price, Dianna D. Cody, Kamna Balhara, Denise M. Juroske, Julie G. Izzo, M. Loreto Spencer, Marie Wislez
Supplementary Figures S1 and S2 from Inhibition of Mammalian Target of Rapamycin Reverses Alveolar Epithelial Neoplasia Induced by Oncogenic K-ras
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aab1696b0ba7cb8f8a6a77ae08465e96
https://doi.org/10.1158/0008-5472.22364258
https://doi.org/10.1158/0008-5472.22364258
Autor:
Jonathan M. Kurie, Ignacio I. Wistuba, Walter N. Hittelman, Roger E. Price, Dianna D. Cody, Kamna Balhara, Denise M. Juroske, Julie G. Izzo, M. Loreto Spencer, Marie Wislez
Supplementary Figure Legends from Inhibition of Mammalian Target of Rapamycin Reverses Alveolar Epithelial Neoplasia Induced by Oncogenic K-ras
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ebe2cbdd813c9d8c7a69e0b17b8d2f1
https://doi.org/10.1158/0008-5472.22364261.v1
https://doi.org/10.1158/0008-5472.22364261.v1
Autor:
Jonathan M. Kurie, Ignacio I. Wistuba, Walter N. Hittelman, Roger E. Price, Dianna D. Cody, Kamna Balhara, Denise M. Juroske, Julie G. Izzo, M. Loreto Spencer, Marie Wislez
The serine/threonine kinase AKT and its downstream mediator mammalian target of rapamycin (mTOR) are activated in lung adenocarcinoma, and clinical trials are under way to test whether inhibition of mTOR is useful in treating lung cancer. Here, we re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::192af149af97169341e98767530cc82d
https://doi.org/10.1158/0008-5472.c.6494108
https://doi.org/10.1158/0008-5472.c.6494108